Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 15.06.2026 1 AJR Am J Roentgenol 3 BJU Int 3 BMC Cancer 1 BMC Urol 1 Cancer Imaging 1 Eur J Radiol 3 Eur Urol 1 Int J Cancer 1 Int J Urol 1 Invest Radiol 1 J Natl Cancer Inst 2 J Nucl Med 2 J Urol 2 Lancet Oncol 1 Magn Reson Imaging 2 Nat Rev Urol 2 Oncogene 1 PLoS One 2 Prostate 2 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. COSTA DN, Gupta AC, Shah RB, Cheney SM, et al
   Anatomy of the Prostate and Periprostatic Region: A Contemporary Review, From the AJR Special Series on Critical Anatomy.
   AJR Am J Roentgenol. 2026;226:e2533454.
   PubMed         Abstract available
   
   

   
   BJU Int

2. BOSHARI T, Anderson A, Richards M
   More harm than good? The UK National Screening Committee's latest review of prostate cancer screening.
   BJU Int. 2026 Jun 8. doi: 10.1111/bju.70355.
   PubMed         Abstract available
   
   
3. 
   Focus on the management of prostate cancer.
   BJU Int. 2026;138:6-7.
   PubMed        
   
   
4. CHENG HH, Maxwell KN, Salari K, Cooperberg MR, et al
   The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.
   BJU Int. 2026 Jun 9. doi: 10.1111/bju.70334.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. QIAN Y, Zhu W, Fang Z, Luo Z, et al
   Integrating DNA methylation and clinical features to predict prostate cancer prognosis.
   BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16249.
   PubMed         Abstract available
   
   
6. PEDERSEN CA, Wess M, Andersen MK, Midtbust E, et al
   Integrated multi-omics profiling uncovers the epigenetic, transcriptional, and metabolic landscape of prostate cancer progression.
   BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16232.
   PubMed         Abstract available
   
   
7. GONG Q, Ge F, Chen T
   A systematic review and meta-analysis of treatment-induced hypertension risks from androgen receptor pathway inhibitors in randomized controlled trials for prostate cancer.
   BMC Cancer. 2026 Jun 11. doi: 10.1186/s12885-026-16284.
   PubMed         Abstract available
   
   

   
   BMC Urol

8. YANG T, Zhang Q, Liu Z, Tian J, et al
   Diagnostic value of PSA-based markers in prostate cancer: a retrospective analysis stratified by body mass index.
   BMC Urol. 2026 Jun 6. doi: 10.1186/s12894-026-02208.
   PubMed         Abstract available
   
   

   
   Cancer Imaging

9. CUI J, Liu Y, Wang G, Xu X, et al
   [(18)F] PSMA-3Q PET/CT radiomics at 45% SUVmax threshold: predicting post-surgical ISUP grade >/= 4 and extraprostatic extension for noninvasive stratification in prostate cancer management.
   Cancer Imaging. 2026 Jun 6. doi: 10.1186/s40644-026-01050.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

10. HIGAKI A, Tamada T, Takeuchi M, Ueda Y, et al
    Impact of a commercial artificial intelligence decision-support system on biparametric MRI interpretation for detecting clinically significant prostate cancer: a retrospective single-center prostatectomy-validated multi-reader study across experience
    Eur J Radiol. 2026;203:112964.
    PubMed         Abstract available
    
    

    
    Eur Urol

11. KISHAN AU, Francolini G, Murphy DG, Eapen RS, et al
    A Multidisciplinary Approach to Prevention and Treatment of Late Genitourinary Adverse Events After Radiotherapy for Prostate Cancer.
    Eur Urol. 2026 Jun 6:S0302-2838(26)02170-6. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    
12. FROEHNER M
    Re: Brian F. Chapin, Marc Smaldone, Amado J. Zurita, et al. A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer. Eur Urol. In Press.
    Eur Urol. 2026 Jun 9:S0302-2838(26)02188-3. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    
13. COVAS MOSCHOVAS M, Falagario U, Pellegrino F, Wiklund P, et al
    Reply to Alexander Light, Max Peters, Manit Arya, et al's Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer. JAMA Oncol 2026;12:364-73. https://doi.org/10.1001/jamaoncol.2025.6448.
    Eur Urol. 2026 Jun 11:S0302-2838(26)02210-4. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    

    
    Int J Cancer

14. 
    RETRACTION: Polygenic Risk Score and Prostate Specific Antigen Predict Death From Prostate Cancer in Men With Intermediate Aggressive Cancer.
    Int J Cancer. 2026 Jun 10. doi: 10.1002/ijc.70578.
    PubMed         Abstract available
    
    

    
    Int J Urol

15. HAGIMOTO H, Kubota M, Mizuno K, Sumiyoshi T, et al
    Younger Age Is Associated With Early Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy.
    Int J Urol. 2026;33:e70535.
    PubMed         Abstract available
    
    

    
    Invest Radiol

16. LEE KL, Gill AB, Kessler DA, Liao PH, et al
    Diffusion-weighted Imaging Distortion in Prostate MRI: A Cross-sectional Study Comparing Supine and Prone Positioning.
    Invest Radiol. 2026;61:467-476.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

17. SUD A, Houlston RS
    Re: Polygenic risk scores for pre-MRI risk stratification in men with clinically suspected prostate cancer.
    J Natl Cancer Inst. 2026 Jun 11:djag179. doi: 10.1093.
    PubMed        
    
    

    
    J Nucl Med

18. BAUCKNEHT M, Belgioia L, Albano D, Triggiani L, et al
    Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort.
    J Nucl Med. 2026 Jun 11:jnumed.125.271680. doi: 10.2967/jnumed.125.271680.
    PubMed         Abstract available
    
    
19. CAKAL BA, Pirkovets K, Ottens VA, Zuur L, et al
    Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.
    J Nucl Med. 2026;67:864-870.
    PubMed         Abstract available
    
    

    
    J Urol

20. GONZALEZ-CARRANZA HR, Reyes-Vallejo LA
    Letter: Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy Versus Inadequacy.
    J Urol. 2026;216:118-119.
    PubMed        
    
    
21. GEORGE A, Giesler E, Mazzarella B, Levin R, et al
    Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.
    J Urol. 2026 Jun 10:101097JU0000000000005156. doi: 10.1097/JU.0000000000005156.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

22. BUTEAU JP, Moon D, Fahey MT, Roberts MJ, et al
    Effect of [(68)Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial.
    Lancet Oncol. 2026 Jun 10:S1470-2045(26)00120.
    PubMed         Abstract available
    
    
23. GOURD E
    UK prostate cancer screening trial to include more Black men.
    Lancet Oncol. 2026 Jun 11:S1470-2045(26)00293.
    PubMed        
    
    

    
    Magn Reson Imaging

24. OZDEMIR O
    MRI-derived real PSA density for risk stratification of PI-RADS 3 lesions: A rule-in approach for clinically significant prostate cancer.
    Magn Reson Imaging. 2026 Jun 10:110732. doi: 10.1016/j.mri.2026.110732.
    PubMed         Abstract available
    
    

    
    Nat Rev Urol

25. BERNARDINO RM, Lobo J, Kaouk J, van der Kwast T, et al
    Atypical intraductal proliferation in prostate biopsy - a diagnostic grey zone with clinical implications.
    Nat Rev Urol. 2026;23:374-384.
    PubMed         Abstract available
    
    
26. CRADDOCK J, Hayes VM
    Epigenetic modulation of prostate cancer disparities in men with African ancestry.
    Nat Rev Urol. 2026 Jun 5. doi: 10.1038/s41585-026-01157.
    PubMed         Abstract available
    
    

    
    Oncogene

27. YANG M, Chen Y, Lai S, Liang X, et al
    MCCC2 stabilizes LTBP1 via suppressing SMURF1-dependent ubiquitination to drive bone metastasis in prostate cancer.
    Oncogene. 2026 Jun 6. doi: 10.1038/s41388-026-03843.
    PubMed         Abstract available
    
    
28. GASPAR LOPES J, Markovic A, Champy CM, Aubourg N, et al
    CDO1 is a new biomarker to discriminate aggressive forms of prostate cancer.
    Oncogene. 2026 Jun 9. doi: 10.1038/s41388-026-03842.
    PubMed         Abstract available
    
    

    
    PLoS One

29. JUAREZ CASILLAS JE, Nezafat M, Benitez CM, Rzechowski K, et al
    Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases.
    PLoS One. 2026;21:e0349825.
    PubMed         Abstract available
    
    

    
    Prostate

30. LI EV, Ahmed EE, Ahmed ME, Wang MK, et al
    Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria.
    Prostate. 2026 Jun 8. doi: 10.1002/pros.70206.
    PubMed         Abstract available
    
    
31. ZHANG S, Sheng Y, Wang Y, Zhu S, et al
    Comprehensive Characterization of Metastatic Patterns and a Redefined Prognostic Framework in Metastatic Prostate Cancer.
    Prostate. 2026 Jun 9. doi: 10.1002/pros.70204.
    PubMed         Abstract available
    
    

    
    Urology

32. OZTURK E, Bolat A, Canbolat MZ, Cayirli A, et al
    Metronome Rhythm Based Auditory Stimulation Modulates Pain and Anxiety During Transperineal Prostate Biopsy: A Prospective Clinical Study.
    Urology. 2026;212:60-65.
    PubMed         Abstract available
    
    
33. MASON JB, Tallman JE
    Editorial Comment on: "Frailty and Quality of Life in Low-Income, Uninsured Men with Prostate Cancer".
    Urology. 2026 Jun 8:S0090-4295(26)00365-1. doi: 10.1016/j.urology.2026.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum